Cargando…

The treatment-related mortality score is associated with non-fatal adverse events following intensive AML induction chemotherapy

Detalles Bibliográficos
Autores principales: Buckley, S A, Othus, M, Estey, E H, Walter, R B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404219/
https://www.ncbi.nlm.nih.gov/pubmed/25635529
http://dx.doi.org/10.1038/bcj.2014.97
_version_ 1783231554425716736
author Buckley, S A
Othus, M
Estey, E H
Walter, R B
author_facet Buckley, S A
Othus, M
Estey, E H
Walter, R B
author_sort Buckley, S A
collection PubMed
description
format Online
Article
Text
id pubmed-5404219
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-54042192017-05-19 The treatment-related mortality score is associated with non-fatal adverse events following intensive AML induction chemotherapy Buckley, S A Othus, M Estey, E H Walter, R B Blood Cancer J Letter to the Editor Nature Publishing Group 2015-01 2015-01-30 /pmc/articles/PMC5404219/ /pubmed/25635529 http://dx.doi.org/10.1038/bcj.2014.97 Text en Copyright © 2015 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Letter to the Editor
Buckley, S A
Othus, M
Estey, E H
Walter, R B
The treatment-related mortality score is associated with non-fatal adverse events following intensive AML induction chemotherapy
title The treatment-related mortality score is associated with non-fatal adverse events following intensive AML induction chemotherapy
title_full The treatment-related mortality score is associated with non-fatal adverse events following intensive AML induction chemotherapy
title_fullStr The treatment-related mortality score is associated with non-fatal adverse events following intensive AML induction chemotherapy
title_full_unstemmed The treatment-related mortality score is associated with non-fatal adverse events following intensive AML induction chemotherapy
title_short The treatment-related mortality score is associated with non-fatal adverse events following intensive AML induction chemotherapy
title_sort treatment-related mortality score is associated with non-fatal adverse events following intensive aml induction chemotherapy
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404219/
https://www.ncbi.nlm.nih.gov/pubmed/25635529
http://dx.doi.org/10.1038/bcj.2014.97
work_keys_str_mv AT buckleysa thetreatmentrelatedmortalityscoreisassociatedwithnonfataladverseeventsfollowingintensiveamlinductionchemotherapy
AT othusm thetreatmentrelatedmortalityscoreisassociatedwithnonfataladverseeventsfollowingintensiveamlinductionchemotherapy
AT esteyeh thetreatmentrelatedmortalityscoreisassociatedwithnonfataladverseeventsfollowingintensiveamlinductionchemotherapy
AT walterrb thetreatmentrelatedmortalityscoreisassociatedwithnonfataladverseeventsfollowingintensiveamlinductionchemotherapy
AT buckleysa treatmentrelatedmortalityscoreisassociatedwithnonfataladverseeventsfollowingintensiveamlinductionchemotherapy
AT othusm treatmentrelatedmortalityscoreisassociatedwithnonfataladverseeventsfollowingintensiveamlinductionchemotherapy
AT esteyeh treatmentrelatedmortalityscoreisassociatedwithnonfataladverseeventsfollowingintensiveamlinductionchemotherapy
AT walterrb treatmentrelatedmortalityscoreisassociatedwithnonfataladverseeventsfollowingintensiveamlinductionchemotherapy